CN1390604A - 大规模连续生产病毒疫苗的方法 - Google Patents
大规模连续生产病毒疫苗的方法 Download PDFInfo
- Publication number
- CN1390604A CN1390604A CN02112013A CN02112013A CN1390604A CN 1390604 A CN1390604 A CN 1390604A CN 02112013 A CN02112013 A CN 02112013A CN 02112013 A CN02112013 A CN 02112013A CN 1390604 A CN1390604 A CN 1390604A
- Authority
- CN
- China
- Prior art keywords
- virus
- cell
- vaccine
- rabies
- bioreactor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000700605 Viruses Species 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 36
- 229960005486 vaccine Drugs 0.000 title claims description 19
- 238000010924 continuous production Methods 0.000 title claims description 8
- 229920000728 polyester Polymers 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 10
- 229960004854 viral vaccine Drugs 0.000 claims abstract description 8
- 210000004027 cell Anatomy 0.000 claims description 47
- 229960003127 rabies vaccine Drugs 0.000 claims description 20
- 239000001963 growth medium Substances 0.000 claims description 18
- 210000003501 vero cell Anatomy 0.000 claims description 14
- 239000005723 virus inoculator Substances 0.000 claims description 10
- 206010061192 Haemorrhagic fever Diseases 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 4
- 229940124859 Rotavirus vaccine Drugs 0.000 claims description 3
- 229960001539 poliomyelitis vaccine Drugs 0.000 claims description 3
- 101100230376 Acetivibrio thermocellus (strain ATCC 27405 / DSM 1237 / JCM 9322 / NBRC 103400 / NCIMB 10682 / NRRL B-4536 / VPI 7372) celI gene Proteins 0.000 claims description 2
- 241000699802 Cricetulus griseus Species 0.000 claims description 2
- 210000001672 ovary Anatomy 0.000 claims description 2
- 230000008569 process Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000012258 culturing Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 14
- 239000000047 product Substances 0.000 description 7
- 206010037742 Rabies Diseases 0.000 description 6
- 210000003292 kidney cell Anatomy 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 208000036142 Viral infection Diseases 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000004113 cell culture Methods 0.000 description 5
- 238000011081 inoculation Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 230000009385 viral infection Effects 0.000 description 5
- 241000699800 Cricetinae Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 235000001727 glucose Nutrition 0.000 description 4
- 238000003306 harvesting Methods 0.000 description 4
- 241000711798 Rabies lyssavirus Species 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- 210000004748 cultured cell Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000005096 rolling process Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241000282552 Chlorocebus aethiops Species 0.000 description 2
- 102000003951 Erythropoietin Human genes 0.000 description 2
- 108090000394 Erythropoietin Proteins 0.000 description 2
- 102000008100 Human Serum Albumin Human genes 0.000 description 2
- 108091006905 Human Serum Albumin Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 230000001186 cumulative effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940105423 erythropoietin Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000002572 peristaltic effect Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 102000013566 Plasminogen Human genes 0.000 description 1
- 108010051456 Plasminogen Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 231100000636 lethal dose Toxicity 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021120137A CN1234412C (zh) | 2002-06-10 | 2002-06-10 | 大规模连续生产病毒疫苗的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021120137A CN1234412C (zh) | 2002-06-10 | 2002-06-10 | 大规模连续生产病毒疫苗的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1390604A true CN1390604A (zh) | 2003-01-15 |
CN1234412C CN1234412C (zh) | 2006-01-04 |
Family
ID=4741856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021120137A Expired - Fee Related CN1234412C (zh) | 2002-06-10 | 2002-06-10 | 大规模连续生产病毒疫苗的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1234412C (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011091565A1 (zh) * | 2010-02-01 | 2011-08-04 | 上海比昂生物医药科技有限公司 | 病毒载体的生产方法 |
CN102154220A (zh) * | 2010-12-30 | 2011-08-17 | 浙江易邦生物技术有限公司 | 超高密度大规模产猪繁殖与呼吸综合征病毒的方法及设备 |
CN102205116A (zh) * | 2010-03-29 | 2011-10-05 | 杭州安普生物工程有限公司 | 一种培养动物细胞生产疫苗的方法 |
CN102268411A (zh) * | 2011-08-15 | 2011-12-07 | 江苏省农业科学院 | Ibdv无血清微载体悬浮培养增殖的方法 |
CN102703391A (zh) * | 2012-05-30 | 2012-10-03 | 广东温氏食品集团有限公司 | 一种采用篮式反应器发酵制备猪圆环病毒的方法 |
CN101869702B (zh) * | 2009-04-21 | 2013-08-14 | 施怀哲维克有限公司 | 以悬浮微载体细胞培养系统产制的疫苗及其方法 |
CN105969737A (zh) * | 2016-05-17 | 2016-09-28 | 丽珠集团疫苗工程股份有限公司 | 一种规模化生产轮状病毒疫苗的方法 |
CN106047821A (zh) * | 2016-05-17 | 2016-10-26 | 丽珠集团疫苗工程股份有限公司 | 一种利用生物反应器规模化生产轮状病毒疫苗的方法 |
CN109055321A (zh) * | 2018-08-27 | 2018-12-21 | 武汉博沃生物科技有限公司 | 一种轮状病毒的培养方法 |
CN111793611A (zh) * | 2020-07-14 | 2020-10-20 | 安徽安科生物工程(集团)股份有限公司 | 一种用生物反应器罐流培养溶瘤腺病毒的工艺优化方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101928693A (zh) * | 2010-06-25 | 2010-12-29 | 辽宁安迪生物技术有限公司 | 一种原代细胞的培养方法 |
-
2002
- 2002-06-10 CN CNB021120137A patent/CN1234412C/zh not_active Expired - Fee Related
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101869702B (zh) * | 2009-04-21 | 2013-08-14 | 施怀哲维克有限公司 | 以悬浮微载体细胞培养系统产制的疫苗及其方法 |
WO2011091565A1 (zh) * | 2010-02-01 | 2011-08-04 | 上海比昂生物医药科技有限公司 | 病毒载体的生产方法 |
CN102205116A (zh) * | 2010-03-29 | 2011-10-05 | 杭州安普生物工程有限公司 | 一种培养动物细胞生产疫苗的方法 |
CN102154220A (zh) * | 2010-12-30 | 2011-08-17 | 浙江易邦生物技术有限公司 | 超高密度大规模产猪繁殖与呼吸综合征病毒的方法及设备 |
CN102268411A (zh) * | 2011-08-15 | 2011-12-07 | 江苏省农业科学院 | Ibdv无血清微载体悬浮培养增殖的方法 |
CN102703391B (zh) * | 2012-05-30 | 2013-10-16 | 广东温氏食品集团股份有限公司 | 一种采用篮式反应器发酵制备猪圆环病毒的方法 |
CN102703391A (zh) * | 2012-05-30 | 2012-10-03 | 广东温氏食品集团有限公司 | 一种采用篮式反应器发酵制备猪圆环病毒的方法 |
CN105969737A (zh) * | 2016-05-17 | 2016-09-28 | 丽珠集团疫苗工程股份有限公司 | 一种规模化生产轮状病毒疫苗的方法 |
CN106047821A (zh) * | 2016-05-17 | 2016-10-26 | 丽珠集团疫苗工程股份有限公司 | 一种利用生物反应器规模化生产轮状病毒疫苗的方法 |
CN106047821B (zh) * | 2016-05-17 | 2019-07-09 | 丽珠集团疫苗工程股份有限公司 | 一种利用生物反应器规模化生产轮状病毒疫苗的方法 |
CN105969737B (zh) * | 2016-05-17 | 2019-09-13 | 丽珠集团疫苗工程股份有限公司 | 一种规模化生产轮状病毒疫苗的方法 |
CN109055321A (zh) * | 2018-08-27 | 2018-12-21 | 武汉博沃生物科技有限公司 | 一种轮状病毒的培养方法 |
CN111793611A (zh) * | 2020-07-14 | 2020-10-20 | 安徽安科生物工程(集团)股份有限公司 | 一种用生物反应器罐流培养溶瘤腺病毒的工艺优化方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1234412C (zh) | 2006-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101979515B (zh) | 兽用狂犬病病毒与疫苗及二者的生产方法 | |
CN1234412C (zh) | 大规模连续生产病毒疫苗的方法 | |
CN1970080A (zh) | 用悬浮的Vero细胞生产病毒疫苗的方法 | |
CN102115729B (zh) | 无血清培养bhk21细胞的方法和制备疫苗的方法 | |
CN101979519A (zh) | 一种制备伪狂犬病疫苗的方法 | |
CN101979514B (zh) | 猪蓝耳病病毒与疫苗及二者的生产方法 | |
CN102240400A (zh) | 一种应用生物反应器及片状载体生产狂犬疫苗的方法 | |
CN103898041A (zh) | 杂交瘤细胞的培养方法 | |
CN103773741A (zh) | 笼式通气搅拌生物反应器制备流感疫苗的方法 | |
CN101352570A (zh) | 二倍体细胞狂犬疫苗及纯化狂犬疫苗的制备方法 | |
CN1238495C (zh) | 动物细胞多孔微载体固定化高效培养方法及其培养基 | |
CN102994547B (zh) | 重组人促红素-ctp融合蛋白生产工艺及应用 | |
CN101524536A (zh) | 人胚肺成纤维细胞乙型脑炎疫苗及其制备方法 | |
CN103764815A (zh) | 用于悬液细胞培养的方法和系统 | |
CN103285390B (zh) | 一种制备狂犬病疫苗的方法 | |
CN102038943A (zh) | 应用生物反应器工业化生产猪乙型脑炎疫苗的方法 | |
CN102002481A (zh) | 猪呼吸与繁殖障碍综合征病毒的生产方法 | |
CN1164737C (zh) | 利用枯草芽孢杆菌NX-2制备γ-聚谷氨酸及其盐和谷胱甘肽及其前体 | |
CN102327609B (zh) | 一种乙型脑炎疫苗的生产方法 | |
CN102776260A (zh) | 一种高效表达重组人凝血八因子的方法 | |
CN1242059C (zh) | rDSPAα I 的产生方法 | |
CN111662881B (zh) | 新型冠状病毒Vero细胞灭活疫苗病毒液及其生产方法 | |
CN102115728A (zh) | 无血清动物细胞培养基干粉、液体培养基及其制备方法 | |
CN1369550A (zh) | 一种金黄色葡萄球菌的培养物及其制备方法 | |
CN1299768C (zh) | 人用二倍体细胞乙型脑炎纯化疫苗的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Liaoning Chengda Biology Co., Ltd. Assignor: Enpei Scientific Instrument Consult Co., Ltd., Shanghai Contract fulfillment period: 2008.12.26 to 2015.12.25 Contract record no.: 2009210000075 Denomination of invention: Method for large-scale continuous production of virus vaccine Granted publication date: 20060104 License type: Exclusive license Record date: 20090402 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.12.26 TO 2015.12.25; CHANGE OF CONTRACT Name of requester: LIAONING CHENGDA BIOLOGICGAL CO., LTD. Effective date: 20090402 |
|
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Liaoning Chengda Biology Co., Ltd. Assignor: Enpei Scientific Instrument Consult Co., Ltd., Shanghai Contract record no.: 2009210000075 Date of cancellation: 20180928 |
|
EC01 | Cancellation of recordation of patent licensing contract | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060104 Termination date: 20200610 |
|
CF01 | Termination of patent right due to non-payment of annual fee |